Eterna Therapeutics
ERNA
#10319
Rank
ยฃ8.02 M
Marketcap
ยฃ1.02
Share price
4.62%
Change (1 day)
-74.44%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2025 (TTM): ยฃ0 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0 Million. In 2024 the company made a revenue of ยฃ0.46 Million an increase over the revenue in the year 2023 that were of ยฃ0.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0 M-99.83%
2024 ยฃ0.46 M768.9%
2023 ยฃ0.05 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Baxter
BAX
ยฃ8.28 B 1,102,299,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.13 B 18,340,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.72 B 4,752,507,999.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
ยฃ0.91 B 121,673,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
ยฃ12.85 M 1,710,185.10%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
ยฃ12.61 B 1,677,599,900.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel